IMULAN Creates Clinical Website For Veterinarians
Main Category: VeterinaryArticle Date: 08 Oct 2008 - 3:00 PDT
Imulan BioTherapeutics, LLC (IMULAN) announced they have launched a new clinical trial website, http://www.IMULANtrials.com, to accommodate their growing comparative research and clinical trial program. The new website will provide veterinarians information regarding IMULAN's ongoing and future trials, including trials for atopic dermatitis, feline stomatitis, asthma, leukemia virus, and other diseases associated with infections or immune mediated disorders.
About the Technologies
Imulan is developing three immune regulating technologies for veterinary medicine, being LTCI, ImSAIDs, and TCR Vax.
LTCI: Lymphocyte T-Cell Immunomodulator is a biologic that has received a conditional license as a treatment aid for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infections and their associated symptoms including opportunistic infection and anemia.
ImSAIDs: The Immune Selective Anti-Inflammatory Derivatives are rapidly acting, orally active natural biological peptides that are being investigated for their use in controlling inappropriate immune responses associated with sepsis, anaphylaxis, acute trauma, pancreatitis, cystitis, allergies and asthma.
TCR Vax: T-Cell Receptor Peptide Vaccines modulate T-helper cell responses, including restoring immune function in aged animals and restoring Th1/Th2 cytokine signaling profiles. TCR Vax is a lead candidate for canine atopic dermatitis and has recently shown promise in feline stomatitis.
About Imulan
Imulan develops unique, precision immune regulating compounds for veterinary medicine. Imulan's primary focus is on biological strategies that combine peptide pharmacology with immunology to treat infectious, autoimmune, and immune mediated diseases in small and large animal medicine. IMULAN recently commercialized Lymphocyte T-Cell Immunomodulator as a conditionally licensed treatment aid for cats infected with feline leukemia and immunodeficiency virus.
Imulan
|
Please rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add to:
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
| Back to top | Back to front page | List of All Medical Articles |
| Privacy Policy | Terms and Conditions | © 2008 MediLexicon International Ltd |





